Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Elmar Kraus is an analyst at DZ Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/12/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
02/21/2024 | LLY | Buy Now | Eli Lilly | $758.51 | 8.11% | Elmar Kraus68% | → $820 | Downgrade | Buy → Hold | Get Alert |
02/11/2022 | GSK | Buy Now | GSK | $37.50 | — | Elmar Kraus68% | — | Downgrade | Buy → Hold | Get Alert |
02/11/2022 | AZN | Buy Now | AstraZeneca | $68.88 | — | Elmar Kraus68% | — | Upgrade | Sell → Hold | Get Alert |
01/21/2022 | LLY | Buy Now | Eli Lilly | $758.51 | -61.64% | Elmar Kraus68% | → $291 | Upgrade | Hold → Buy | Get Alert |
08/05/2021 | LLY | Buy Now | Eli Lilly | $758.51 | -62.03% | Elmar Kraus68% | → $288 | Upgrade | Hold → Buy | Get Alert |
02/04/2021 | PFE | Buy Now | Pfizer | $22.94 | 78.73% | Elmar Kraus68% | → $41 | Upgrade | Hold → Buy | Get Alert |
05/14/2020 | MDT | Buy Now | Medtronic | $85.89 | 7.11% | Elmar Kraus68% | → $92 | Downgrade | Buy → Hold | Get Alert |
03/25/2020 | MDT | Buy Now | Medtronic | $85.89 | 4.79% | Elmar Kraus68% | → $90 | Upgrade | Hold → Buy | Get Alert |
03/18/2020 | GILD | Buy Now | Gilead Sciences | $103.20 | — | Elmar Kraus68% | — | Upgrade | Hold → Buy | Get Alert |
02/28/2020 | GILD | Buy Now | Gilead Sciences | $103.20 | — | Elmar Kraus68% | — | Downgrade | Buy → Hold | Get Alert |
08/28/2019 | PFE | Buy Now | Pfizer | $22.94 | 56.93% | Elmar Kraus68% | → $36 | Upgrade | Sell → Hold | Get Alert |
06/22/2018 | LLY | Buy Now | Eli Lilly | $758.51 | — | Elmar Kraus68% | — | Downgrade | Buy → Hold | Get Alert |